Keyword: AbbVie


AbbVie to Build New Biologics Manufacturing Site in Singapore

30.01.2024 -

Last week, AbbVie broke ground on a new Singapore manufacturing facility located in Singapore's Tuas Biomedical Park. The company will invest $223 million in the site...


AbbVie to Acquire Cerevel Therapeutics for $8.7 Billion

07.12.2023 -

In a move to complement its neuroscience portfolio, US drugmaker AbbVie has agreed to acquire Cerevel Therapeutics, which has a pipeline of multiple clinical-stage and...


AbbVie to Buy Cancer Drug Maker ImmunoGen for $10.1 Billion

01.12.2023 -

US biopharma AbbVie has agreed to acquire ImmunoGen in a deal which values the company at about $10.1 billion and gives AbbVie access to flagship cancer therapy Elahere...

Chemistry & Life Sciences

The Success Story of Biosimilars

13.09.2023 -

With their triumphant advance, biosimilars are also setting in motion the usual market mechanisms. Biopharma interest groups warn against the automatic substitution of...


AbbVie Expands Neuroscience Portfolio with Syndesi Purchase

09.03.2022 -

US biopharma AbbVie is to take over Belgian biotech Syndesi Therapeutics, in a move that will expand its neuroscience portfolio. Under the agreed terms, AbbVie will pay...


AbbVie and Regenxbio Link on Eye Diseases

17.09.2021 -

US biopharmas AbbVie and Regenxbio are forming a strategic partnership to develop and commercialize a gene therapy for eye diseases. The transaction is expected to close...


AbbVie to Sell off Allergan Women’s Health Portfolio

22.03.2021 -

US pharma AbbVie has put compatriot Allergan’s women’s health business up for sale. The company is said to be working with Morgan Stanley on an auction process that has...


AbbVie and Caribou in CAR-T Collaboration

18.02.2021 -

US biopharma AbbVie and compatriot biotech Caribou Biosciences have entered into a multi-year collaboration and license agreement to research and develop chimeric antigen...